GeneDx Holdings Corp (WGS)
20.87
+3.80
(+22.26%)
USD |
NASDAQ |
May 01, 16:00
20.32
-0.55
(-2.64%)
Pre-Market: 08:19
GeneDx Holdings Total Liabilities (Quarterly): 187.31M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 187.31M |
| December 31, 2023 | 190.74M |
| September 30, 2023 | 163.03M |
| June 30, 2023 | 180.28M |
| March 31, 2023 | 216.83M |
| December 31, 2022 | 237.24M |
| Date | Value |
|---|---|
| September 30, 2022 | 267.68M |
| June 30, 2022 | 296.01M |
| March 31, 2022 | 188.23M |
| December 31, 2021 | 165.99M |
| September 30, 2021 | 212.09M |
| December 31, 2020 | 581.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
163.03M
Minimum
Sep 2023
581.69M
Maximum
Dec 2020
240.59M
Average
201.42M
Median
Total Liabilities (Quarterly) Benchmarks
| American Well Corp | 109.52M |
| GoodRx Holdings Inc | 826.84M |
| Privia Health Group Inc | 392.51M |
| Doximity Inc | 136.04M |
| FOXO Technologies Inc | 14.23M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 394.53M |
| Shareholders Equity (Quarterly) | 207.22M |
| Debt to Equity Ratio | 0.2524 |
| Current Ratio | 3.221 |
| Net Debt Paydown Yield | -3.46% |